Innovations For Detecting Cancer Early
source: pixabay.com

Innovations For Detecting Cancer Early

According to a recent article, being able to detect cancer as soon as possible is vitally important as it allows time to administer curative treatments. Scientists are hopeful new treatments…

Continue Reading Innovations For Detecting Cancer Early
Improving NAFLD and NASH Outcomes Through Novel Drug and Histologic Spectrum Focus
source: pixabay.com

Improving NAFLD and NASH Outcomes Through Novel Drug and Histologic Spectrum Focus

  According to a recent article from Physician’s Weekly, two trials recently published are showing the results of striving to improve the management and outcomes in nonalcoholic steatohepatitis (NASH) and…

Continue Reading Improving NAFLD and NASH Outcomes Through Novel Drug and Histologic Spectrum Focus
For Asian Americans the Risk of Developing Nasopharyngeal Carcinoma Varies Amongst Different Ethnic Groups
ckstockphoto / Pixabay

For Asian Americans the Risk of Developing Nasopharyngeal Carcinoma Varies Amongst Different Ethnic Groups

  According to a recent article, a study shows the risk of getting nasopharyngeal carcinoma (NPC) varies considerably in different ethnic groups among Asian Americans. Nasopharyngeal Carcinoma (NPC) Nasopharyngeal carcinoma…

Continue Reading For Asian Americans the Risk of Developing Nasopharyngeal Carcinoma Varies Amongst Different Ethnic Groups
Studies Show Thyroidectomy for Graves’ Disease Have Low Hypoparathyroidism Rates
sabinevanerp / Pixabay

Studies Show Thyroidectomy for Graves’ Disease Have Low Hypoparathyroidism Rates

  According to a recent article from Medscape, older patients being treated for Graves' disease should not be deterred from thyroidectomies, as they result in low rates of hypoparathyroidism. Graves’…

Continue Reading Studies Show Thyroidectomy for Graves’ Disease Have Low Hypoparathyroidism Rates
Insulin/Dextrose as Management for Hyperkalemia Only Transiently Effective
Pixabay: https://pixabay.com/en/medic-hospital-laboratory-medical-563425/

Insulin/Dextrose as Management for Hyperkalemia Only Transiently Effective

According to a recent article, a recent study from the U.K. showed that emergency methods of managing hyperkalemia, such as the use of insulin/dextrose, are not the most effective treatments.…

Continue Reading Insulin/Dextrose as Management for Hyperkalemia Only Transiently Effective
Patients with Chronic Kidney Disease and Hyperkalemia Associated with Major Adverse Cardiovascular Events
Photo by Robina Weermeijer on Unsplash

Patients with Chronic Kidney Disease and Hyperkalemia Associated with Major Adverse Cardiovascular Events

According to a recent article, a study shows patients with nondialysis-dependent chronic kidney disease and transient or chronic hyperkalemia, correspond with major adverse cardiovascular events (MACE) and even death. Chronic…

Continue Reading Patients with Chronic Kidney Disease and Hyperkalemia Associated with Major Adverse Cardiovascular Events

Study for Vision Loss from NF1 Optic Pathway Glioma Funded By Gilbert Family Foundation

According to a recent article, the nonprofit Gilbert Family Foundation has offered to fund the $5.4 million clinical study to better understand vision loss from NF1-associated optic pathway gliomas (NF1-OPGs).…

Continue Reading Study for Vision Loss from NF1 Optic Pathway Glioma Funded By Gilbert Family Foundation
Infections Are Leading Cause of Hospital Death in Indian Patients with Inflammatory Myopathy
vitalworks / Pixabay

Infections Are Leading Cause of Hospital Death in Indian Patients with Inflammatory Myopathy

  According to a recent article, researchers investigated the cause of deaths in the hospital in patients who were diagnosed with inflammatory myositis in a tertiary care center in Northern…

Continue Reading Infections Are Leading Cause of Hospital Death in Indian Patients with Inflammatory Myopathy
PharmaTher Announces the FDA Granted Orphan Drug Designation for Ketamine to Treat Complex Regional Pain Syndrome
Source: Pixabay

PharmaTher Announces the FDA Granted Orphan Drug Designation for Ketamine to Treat Complex Regional Pain Syndrome

  According to a recent article, PharmaTher Holdings Ltd. announces the FDA granted orphan drug designation (ODD) for ketamine in the treatment of complex regional pain syndrome (CRPS). Complex Regional…

Continue Reading PharmaTher Announces the FDA Granted Orphan Drug Designation for Ketamine to Treat Complex Regional Pain Syndrome
Boston Children’s Hospital Granted $308,000 Grant by SynGAP Research Fund
source: pixabay.com

Boston Children’s Hospital Granted $308,000 Grant by SynGAP Research Fund

According to a recent article from BioSpace, Boston’s Children Hospital was granted $308,000 to advance their multidisciplinary biomarker work. SYNGAP1 Syndrome SYNGAP1 syndrome is a neurological disorder that is characterized…

Continue Reading Boston Children’s Hospital Granted $308,000 Grant by SynGAP Research Fund

The Similarities and Differences Between Myasthenia Gravis and Multiple Sclerosis

A recent article from Healthline highlighted the similarities and differences between two neurological diseases, myasthenia gravis (MG) and multiple sclerosis (MS). Myasthenia Gravis Deriving from the Greek and Latin words…

Continue Reading The Similarities and Differences Between Myasthenia Gravis and Multiple Sclerosis

New Machine-Learning Model Shows Individuals If They’re at Risk of Rare Cardiomyopathy

According to a recent article, investigators created a machine learning model in order to identify if patients are at risk of rare cardiomyopathy. Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Transthyretin amyloid cardiomyopathy…

Continue Reading New Machine-Learning Model Shows Individuals If They’re at Risk of Rare Cardiomyopathy

Durvalumab Hopes to be Treatment Option for Malignant Pleural Mesothelioma

According to a recent article from OncologyLive, investigators are looking at durvalumab to aid in the treatment of adults with malignant pleural mesothelioma in the Phase 3 DREAM3R Trial. Malignant…

Continue Reading Durvalumab Hopes to be Treatment Option for Malignant Pleural Mesothelioma